9.24
-0.38 (-3.95%)
| Penutupan Terdahulu | 9.62 |
| Buka | 9.39 |
| Jumlah Dagangan | 319,947 |
| Purata Dagangan (3B) | 690,534 |
| Modal Pasaran | 462,636,672 |
| Harga / Jualan (P/S) | 1.97 |
| Harga / Buku (P/B) | 1.02 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -46.46% |
| Margin Operasi (TTM) | -35.73% |
| EPS Cair (TTM) | -2.36 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 60.85% |
| Nisbah Semasa (MRQ) | 5.56 |
| Aliran Tunai Operasi (OCF TTM) | -17.40 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -89.49 M |
| Pulangan Atas Aset (ROA TTM) | -4.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -24.97% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Integrated Freight & Logistics (US) | Menaik | Menurun |
| Integrated Freight & Logistics (Global) | Bercampur | Menurun | |
| Stok | CryoPort, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.00 |
|
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas. |
|
| Sektor | Industrials |
| Industri | Integrated Freight & Logistics |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.48% |
| % Dimiliki oleh Institusi | 99.07% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Thematics Asset Management | 30 Sep 2025 | 1,638,623 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 15.00 (BTIG, 62.34%) | Beli |
| Median | 12.50 (35.28%) | |
| Rendah | 12.00 (Needham, 29.87%) | Beli |
| Purata | 13.17 (42.53%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 9.04 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 05 Nov 2025 | 12.00 (29.87%) | Beli | 8.53 |
| UBS | 05 Nov 2025 | 12.50 (35.28%) | Beli | 8.53 |
| BTIG | 18 Sep 2025 | 15.00 (62.34%) | Beli | 10.05 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Nov 2025 | Pengumuman | Cryoport Reports Third Quarter 2025 Financial Results |
| 30 Oct 2025 | Pengumuman | Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain |
| 21 Oct 2025 | Pengumuman | Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025 |
| 07 Oct 2025 | Pengumuman | MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars |
| 01 Oct 2025 | Pengumuman | Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |